drugset / Trial / NCT02261883
Remodulin as Add-on Therapy for the Treatment of Persistent Pulmonary Hypertension of the Newborn
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This study assessed the safety and treatment effect of intravenous (IV) Remodulin as an add-on therapy in neonates with persistent pulmonary hypertension of the newborn (PPHN).
Timeline
- Start
- 2015-07-29
- Primary completion
- 2022-09-27
- Completion
- 2023-05-17
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Treprostinil | Other / unclassified | 1 unknown | Intravenous |